VINC
Vincerx Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
+0.00%Margins
Gross margin
-1.0%
EBITDA margin
-2479.4%
EBIT margin
-2558.0%
Net margin
-2120.3%
FCF margin
-2138.8%
-1096.1%
Return on equity
-483.2%
Return on assets
-1322.3%
Return on invested capital
0.17x
Asset turnover
-$22.8M
Cash from operations
$0.85
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2025